The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.

The letter also noted that the company does not monitor how acetaminophen affects glucose sensing with its G7 monitors. The FDA also said Dexcom is not properly evaluating the risk of using the G6 ...

DexCom Inc. DXCM recently announced that its G7 Continuous Glucose Monitoring ... blood glucose readings in real time to a handheld receiver or smart device. Patients can control their glucose ...

Dexcom G7, a continuous glucose monitoring system that allows people with diabetes to track their blood sugar levels in real time, announced Wednesday it's integrating directly with Apple Watch ...

At the conference, first-ever accuracy and performance data will be presented for Dexcom’s upcoming G7 15 Day system, 1 showing an overall mean absolute relative difference (MARD) of 8.0% ...

The Dexcom 15-day G7 continuous glucose monitor (CGM) is accurate and safe for use up to 15.5 days in adults with diabetes. Currently under review by the US Food and Drug Administration ...

Users should always confirm readings and trend on the Dexcom G7 app or receiver before making treatment decisions. * Separate Dexcom Follow app and internet connection required.